Anti-HIV-1 + HIV-2 protease Monoclonal Antibody (Clone:1696)-Azide free
Figure 1: Dot Blot analysis of recombinant HIV protease. The total amount of recombinant HIV-protease spotted on the nitrocellulose membrane are indicated in left column. . Lane 1: anti-HIV protease (1696); 0.2 µg/ml . Lane 2: anti-HIV protease (1696); 1.0 µg/ml . Lane 3: anti-HIV protease (1696); 2.0 µg/ml
| Amount : | 0.1 mg |
| Isotype : | Mouse IgG1 |
| Purification : | Purified by protein-A affinity chromatography |
| Storage condition : | Store at 2-8°C. Do not freeze. |
| Immunogen Information : | Bacterially expressed full-length HIV-1 protease |
The HIV protease (PR) hydrolyzes polyproteins of HIV virus into functional protein products that are essential for its assembly and subsequent activity. This maturation process occurs as the virion buds from the host cell. HIV protease inhibitors are used in the treatment of patients with AIDS and were considered the first breakthrough in over a decade of AIDS research. HIV protease inhibitors can lower the viral load carried by AIDS patents.
Western Blotting 0.5 µg/ml
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
| There are currently no product reviews |